Intellinetics (INLX) had the highest return in February 2012 by a US stock with a market cap of $1,000+, returning 35,600%.

ASSET	MONTH	% RETURN
Intellinetics (INLX)	February 2012	35,600%
Protagenic Therapeutics (PTIX)	February 2012	286.47%
TG Therapeutics (TGTX)	February 2012	277.77%
Cocrystal Pharma (COCP)	February 2012	146%
Energy Focu (EFOI)	February 2012	138.1%
Applied Digital (APLD)	February 2012	130.77%
Precision Optics Corporation, Inc Common stock (POCI)	February 2012	118.18%
Aethlon Medical (AEMD)	February 2012	100%
Recon Technology (RCON)	February 2012	92.5%
PharmaCyte Biotech (PMCB)	February 2012	83.33%
InnovAge (INNV)	February 2012	80%
Eyepoint Pharmaceuticals (EYPT)	February 2012	78.33%
Quest Resource (QRHC)	February 2012	77.78%
OPTIMIZERx (OPRX)	February 2012	75.71%
Oragenics (OGEN)	February 2012	74.17%
Optex Systems Holdings, Inc Common Stock (OPXS)	February 2012	71.43%
Sellas Life Sciences (SLS)	February 2012	69.87%
Heritage Global (HGBL)	February 2012	68%
Red Cat (RCAT)	February 2012	66.67%
Newegg Commerce (NEGG)	February 2012	63.64%
Anixa Biosciences (ANIX)	February 2012	63.64%
Metalla Royalty & Streaming (MTA)	February 2012	62.4%
Plumas Bancorp (PLBC)	February 2012	62.21%
Natural Health Trend (NHTC)	February 2012	61.7%
Magyar Bancorp (MGYR)	February 2012	58.58%